| Product Code: ETC7548641 | Publication Date: Sep 2024 | Product Type: Market Research Report | ||
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The India natural killer (NK) cell therapeutics market import shipments witnessed a declining trend with a negative CAGR from 2020 to 2024. The growth rate between 2023 and 2024 experienced a sharp decrease, indicating a significant slowdown in market expansion during that period.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Natural Killer (NK) Cell Therapeutics Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Natural Killer (NK) Cell Therapeutics Market Revenues & Volume, 2021 & 2031F |
3.3 India Natural Killer (NK) Cell Therapeutics Market - Industry Life Cycle |
3.4 India Natural Killer (NK) Cell Therapeutics Market - Porter's Five Forces |
3.5 India Natural Killer (NK) Cell Therapeutics Market Revenues & Volume Share, By Therapeutics, 2021 & 2031F |
3.6 India Natural Killer (NK) Cell Therapeutics Market Revenues & Volume Share, By Approaches, 2021 & 2031F |
3.7 India Natural Killer (NK) Cell Therapeutics Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 India Natural Killer (NK) Cell Therapeutics Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 India Natural Killer (NK) Cell Therapeutics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer and infectious diseases in India, driving the demand for innovative treatment options like NK cell therapeutics. |
4.2.2 Rising healthcare expenditure and infrastructure development in India, facilitating the adoption and advancement of NK cell therapy. |
4.2.3 Growing research and development activities in the field of immunotherapy, leading to the development of more effective NK cell therapeutics. |
4.3 Market Restraints |
4.3.1 High cost associated with NK cell therapy, limiting access to treatment for a significant portion of the population. |
4.3.2 Regulatory challenges and approval processes for cell-based therapies in India, hindering the market growth. |
4.3.3 Limited awareness and understanding of NK cell therapy among healthcare providers and patients, impacting adoption rates. |
5 India Natural Killer (NK) Cell Therapeutics Market Trends |
6 India Natural Killer (NK) Cell Therapeutics Market, By Types |
6.1 India Natural Killer (NK) Cell Therapeutics Market, By Therapeutics |
6.1.1 Overview and Analysis |
6.1.2 India Natural Killer (NK) Cell Therapeutics Market Revenues & Volume, By Therapeutics, 2021- 2031F |
6.1.3 India Natural Killer (NK) Cell Therapeutics Market Revenues & Volume, By NK Cell Therapies, 2021- 2031F |
6.1.4 India Natural Killer (NK) Cell Therapeutics Market Revenues & Volume, By NK Cell Directed Antibodies, 2021- 2031F |
6.2 India Natural Killer (NK) Cell Therapeutics Market, By Approaches |
6.2.1 Overview and Analysis |
6.2.2 India Natural Killer (NK) Cell Therapeutics Market Revenues & Volume, By Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC), 2021- 2031F |
6.2.3 India Natural Killer (NK) Cell Therapeutics Market Revenues & Volume, By Bispecific Antibodies, 2021- 2031F |
6.3 India Natural Killer (NK) Cell Therapeutics Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 India Natural Killer (NK) Cell Therapeutics Market Revenues & Volume, By Cancer, 2021- 2031F |
6.3.3 India Natural Killer (NK) Cell Therapeutics Market Revenues & Volume, By Immunoproliferative Disorders, 2021- 2031F |
6.3.4 India Natural Killer (NK) Cell Therapeutics Market Revenues & Volume, By Acute Infectious Diseases, 2021- 2031F |
6.3.5 India Natural Killer (NK) Cell Therapeutics Market Revenues & Volume, By Gastrointestinal Diseases, 2021- 2031F |
6.3.6 India Natural Killer (NK) Cell Therapeutics Market Revenues & Volume, By Others, 2021- 2031F |
6.4 India Natural Killer (NK) Cell Therapeutics Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 India Natural Killer (NK) Cell Therapeutics Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.4.3 India Natural Killer (NK) Cell Therapeutics Market Revenues & Volume, By Direct Tender, 2021- 2031F |
6.4.4 India Natural Killer (NK) Cell Therapeutics Market Revenues & Volume, By Others, 2021- 2031F |
7 India Natural Killer (NK) Cell Therapeutics Market Import-Export Trade Statistics |
7.1 India Natural Killer (NK) Cell Therapeutics Market Export to Major Countries |
7.2 India Natural Killer (NK) Cell Therapeutics Market Imports from Major Countries |
8 India Natural Killer (NK) Cell Therapeutics Market Key Performance Indicators |
8.1 Patient response rates to NK cell therapy. |
8.2 Number of clinical trials and research studies conducted on NK cell therapeutics in India. |
8.3 Rate of adoption of NK cell therapy in different healthcare settings. |
8.4 Average survival rates and progression-free survival rates of patients receiving NK cell therapy. |
8.5 Investment and funding trends in the development and commercialization of NK cell therapeutics in India. |
9 India Natural Killer (NK) Cell Therapeutics Market - Opportunity Assessment |
9.1 India Natural Killer (NK) Cell Therapeutics Market Opportunity Assessment, By Therapeutics, 2021 & 2031F |
9.2 India Natural Killer (NK) Cell Therapeutics Market Opportunity Assessment, By Approaches, 2021 & 2031F |
9.3 India Natural Killer (NK) Cell Therapeutics Market Opportunity Assessment, By Application, 2021 & 2031F |
9.4 India Natural Killer (NK) Cell Therapeutics Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 India Natural Killer (NK) Cell Therapeutics Market - Competitive Landscape |
10.1 India Natural Killer (NK) Cell Therapeutics Market Revenue Share, By Companies, 2024 |
10.2 India Natural Killer (NK) Cell Therapeutics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here